For example, persons with lower socioeconomic status and those with specific comorbidities, including congestive heart failure and HIV (human immunodeficiency virus), normally experience significant barriers to care, including the reduced likelihood of filling for novel therapy prescriptions such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Here, GLP1R is linked to congestive heart failure.